1[1]Lacreta FP,Kaul S,Kollia GD,et al.interchangeability of 400 mg intravenous and oral gatifloxacin in healthy adults[J].Pharmacotherapy,2000,20(6pt 2):58
2[2]Lu T,zhao X,drlixa K.Garefloxaxin actiwitu against qrinolone-resistant gyrase:allele-spexifix enhancement of bacteriostatic and bactericidal activitires by the C-8-methoxy group[J].AntimicrobAgents Chemother,1999,43(12):2968
3[3]Miyashita N,Niki Y,Kishimoto T,et al.Invitro and in vivo activities of AM-1155,a new fluoroquinolone,against chlamydia spp[J].Antimicrob Agents Chemother,1997,41(6):1331
4[4]Odland BA,Jones RN,Verhoef J,et al.Antimicrobial activity of gatifloxacn and fore oyher fluoroquinolones tested against 2284 recent clinical strains of strptococcus pneumoniae from europe,latin america,canada,and thr united states[J].Diagn Microbiol Infect Dis,1999,34(4):315
5[5]Lutsar I,Friedland IR,Jafri HS,et al.Efficacy of gatifloxacin in experimental escherichia coli meningitis[J].Antimicrob Agents Chemother,1999,43(7):1805
6[6]Fukuda H,Hiramatsu K.Primary targets of fluoroquinolones in sreeptococcus pneumoniae[J].Antimicrob Agents Chrmother,1999,43(2):410
